Literature DB >> 16365389

Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.

Norman Nausch1, Lore Florin, Bettina Hartenstein, Peter Angel, Marina Schorpp-Kistner, Adelheid Cerwenka.   

Abstract

The activating receptor NKG2D and its ligands RAE-1 play an important role in the NK, gammadelta+, and CD8+ T cell-mediated immune response to tumors. Expression levels of RAE-1 on target cells have to be tightly controlled to allow immune cell activation against tumors but to avoid destruction of healthy tissues. In this study, we report that cell surface expression of RAE-1epsilon is greatly enhanced on cells lacking JunB, a subunit of the transcription complex AP-1. Furthermore, tissue-specific junB knockout mice respond to 12-O-tetradecanoyl-phorbol-13-acetate, a potent AP-1 activator, with markedly increased and sustained epidermal RAE-1epsilon expression. Accordingly, junB-deficient cells are efficiently killed via NKG2D by NK cells and induce IFN-gamma production. Our data indicate that the transcription factor AP-1, which is involved in tumorigenesis and cellular stress responses, regulates RAE-1epsilon. Thus, up-regulated RAE-1epsilon expression due to low levels of JunB could alert immune cells to tumors and stressed cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365389     DOI: 10.4049/jimmunol.176.1.7

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1.

Authors:  Jiuyu Gong; Rongrong Liu; Ran Zhuang; Yun Zhang; Liang Fang; Zhuwei Xu; Liang Jin; Tao Wang; Chaojun Song; Kun Yang; Yuying Wei; Angang Yang; Boquan Jin; Lihua Chen
Journal:  Cancer Sci       Date:  2012-02-13       Impact factor: 6.716

Review 3.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Junb regulates arterial contraction capacity, cellular contractility, and motility via its target Myl9 in mice.

Authors:  Alexander H Licht; Tobias Nübel; Anja Feldner; Nathalie Jurisch-Yaksi; Marco Marcello; Elena Demicheva; Jun-Hao Hu; Bettina Hartenstein; Hellmut G Augustin; Markus Hecker; Peter Angel; Thomas Korff; Marina Schorpp-Kistner
Journal:  J Clin Invest       Date:  2010-06-14       Impact factor: 14.808

5.  The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.

Authors:  Oriane Cédile; Natalia Popa; Frédéric Pollet-Villard; Nicolas Garmy; El Chérif Ibrahim; José Boucraut
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 6.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

Authors:  David H Raulet; Nadia Guerra
Journal:  Nat Rev Immunol       Date:  2009-08       Impact factor: 53.106

Review 7.  Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.

Authors:  Ahmed El-Gazzar; Veronika Groh; Thomas Spies
Journal:  J Immunol       Date:  2013-08-15       Impact factor: 5.422

8.  Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.

Authors:  Norman Nausch; Ioanna E Galani; Eva Schlecker; Adelheid Cerwenka
Journal:  Blood       Date:  2008-08-27       Impact factor: 22.113

9.  An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis.

Authors:  Maroesja J van Nimwegen; Saertje Verkoeijen; Peter J K Kuppen; Jurjen H L Velthuis; Bob van de Water
Journal:  Clin Exp Metastasis       Date:  2007-05-31       Impact factor: 5.150

10.  New twist on the regulation of NKG2D ligand expression.

Authors:  Adelheid Cerwenka
Journal:  J Exp Med       Date:  2009-02-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.